Arca
Skip to content

B40i Patient Monitor

Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms). 510(k) K143676, from GE Healthcare Finland Oy (Helsinki, FI). Product code MHX, class 2.

As of Nov 17, 2026, K143676 is an FDA 510(k) held by GE Healthcare Finland Oy, substantially equivalent on Jul 31, 2015 after 219 days, with 1 recall tied to it in FDA's recall database.

  • Substantially equivalent: Jul 31, 2015
  • Review time: 219 days
  • Recalls: 1
  • Cited as a predicate by: 1 device

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

1 later 510(k) summary names this device as a predicate

Recalls

Recalls FDA ties to K143676, newest first; each opens FDA's recall record
StartedReasonStatus
Sep 11, 2018Z-0586-2019Patient monitors may restart due to network overload caused by network configuration.Open, Classified

Other MHX Clearances

The newest 510(k)s for the same product code; their median review was 226 days; see every MHX device

Record

Type
Traditional
Received
Dec 24, 2014
Review panel
Cardiovascular
Regulation
21 CFR 870.1025

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.